An HDAC inhibitor for treating cancer with a modified STK11 activity or expression
MYPI2025000831A0Undetermined Publication Date: 2024-02-05TANGO THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025000831
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-14
- Filing Date
- 2023-08-04
- Publication Date
- 2024-02-05
Smart Images

Figure PI2025000831_DRAWING_001 
Figure PI2025000831_DRAWING_002 
Figure PI2025000831_DRAWING_003
Abstract
The disclosure relates to methods of treating cancers, including cancers having modified STK11 activity or expression, by administering an effective amount of a histone deacetylase (HDAC) inhibitor. [Figure 1A]
Need to check novelty before this filing date? Find Prior Art
